Auraptene
SIGMA/A9861 - ≥98% (HPLC)
Synonym: 7-Geranyloxycoumarin; 7-
CAS Number: 495-02-3
Empirical Formula (Hill Notation): C19H22O3
Molecular Weight: 298.38
MDL Number: MFCD00075948
Linear Formula: C19H22O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C19H22O3/c1-14(2)5-4-6 |
| InChI key | RSDDHGSKLOSQFK-RVDMUPIBSA |
| Quality Level | 100 ![]() |
| SMILES string | CC(C)=CCCC(C)=CCOc1cc |
| solubility | DMSO: >20 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Auraptene is an ACAT inhibitor and estrogen receptor modulator. |
| Biochem/physiol Actions: | Auraptene is an estrogen receptor modulator that also acts as an ACAT inhibitor. It displays anti-tumor effects in several xenograft and chemically-induced murine tumor models. Auraptene induces apoptosis and is anti-proliferative in cancer cell lines. It has agonistic properties against PPARs, and interferes with lipid and cholesterol production by inhibiting ACAT (IC50 = 4 uM). |
| Biochem/physiol Actions: | Auraptene (7-geranyloxyco |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: | Auraptene (7-geranyloxyco |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

